Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Axitinib in Adrenocortical Cancer
NCT01255137Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Sep 2010
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of axitinib in adrenocortical carcinoma (ACC), sponsored by National Cancer Institute. Started Sep 2010; status: completed.
02
Drugs
axitinib
03
Conditions
adrenocortical carcinoma (ACC)
Beyond the preview
Go deeper on NCT01255137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01255137.